About the Event

The WA Life Sciences Innovation Hub invites you to our next WA MTP Sector Spotlight Series event, a fireside chat focused on medtech commercialisation with Jill Anderson (OncoRes Medical Non-Executive Director) sharing her experiences in the US and Dr Kath Giles (OncoRes Medical CEO/MD; Brandon Capital Venture Partner) providing the Australian perspective.

About our topic

During this event we will gain insights into medtech commercialisation from two leaders, a successful founder from the US and the CEO of fast-growing WA start-up, OncoRes Medical.

OncoRes Medical’s Non-Executive Director Ms Jill Anderson brings a wealth of knowledge and expertise about the American medtech landscape. Jill has extensive experience as the Co-Founder, President and CEO of Cianna Medical (acquired in 2018 for $200M), as well as Director of OncoRes, Minerva Surgical and Merit Medical Systems.

OncoRes Medical’s CEO and MD Dr Kath Giles will offer insights from her experience as a business leader, clinician, innovator and investor, and her perspective on what it takes to commercialise medtech in WA.

Through this fireside chat led by WA Life Sciences Innovation Hub’s Dr Tracey Wilkinson, we aim to foster a vibrant conversation about what it takes to successfully bring a novel medical technology to market to benefit patients. Whether you are an aspiring entrepreneur, industry professional, investor, or simply interested in the field, this event promises to provide valuable perspectives on the global medtech industry.

About this event

Our monthly event series is an opportunity for representatives from across the MTP sector to connect, collaborate and learn about upcoming opportunities, and hear the stories and successes of WA organisations developing health and medical innovations. Join us for networking and conversation over light refreshments afterwards.

We’re pleased to be delivering this event in partnership with The Centre for Entrepreneurial Research and Innovation (CERI), a social enterprise supporting the next generation of WA’s entrepreneurs. Their programs have been designed to educate and empower early-stage entrepreneurs, PhD students and visionaries within the WA community.

About OncoRes Medical

Founded in 2016, OncoRes Medical is a Perth-based medical device company dedicated to eliminating the burdens associated with repeat operations following breast-conserving surgery (BCS). The company is developing a hand-held, real-time intraoperative imaging device to improve the detection of residual tumour in the surgical cavity, providing surgeons with the confidence that no residual cancer remains in the breast. This innovative solution is based on technology developed in collaboration with the University of Western Australia and Western Australian Department of Health. Learn more at www.oncoresmedical.com.

About our speakers

Dr Katharine Giles – CEO/Managing Director

Dr Kath Giles has been CEO/Managing Director of OncoRes since 2017. Kath has experience on both sides of the funding process, having worked as an Investment Manager at Stone Ridge Ventures and then joining Brandon Capital Partners in 2012 as a Venture Partner. Kath has start-up experience in medical apps, diagnostics and fitness devices and continues to practice as a medical doctor working within the surgical field. Before entering the commercial world, Kath spent time working in clinical medicine gaining a range of experience across medical and surgical specialities and critical care. Kath combines her investment experience and clinical knowledge with a keen business insight. She is a Director of Respirion Pharmaceuticals, Non-Executive Director of Sonic Healthcare and a founding Committee Member of the Australian Society for Medical Entrepreneurship & Innovation (ASME).

She is also a Graduate of the Australian Institute of Company Directors.

Jill Anderson – Non-Executive Director

Ms Jill Anderson is dedicated to enhancing the lives of consumers through medical technology. Jill is a business strategist and commercial expert with extensive industry experience in medical devices and healthcare services. She was Co-Founder, President and Chief Executive Officer of Cianna Medical from 2008 until its acquisition in 2018. Prior to that, she was Vice President of BioLucent from 2001 to 2003, becoming President in 2003 until its acquisition in 2007.

Prior to entering the medical device field, Jill held executive leadership positions in health care services, focused on developing patient-centric, comprehensive cancer centers in partnership with large, teaching hospital environments. In addition to her service on the OncoRes Board, Jill also serves on the Board of Minerva Surgical, a uterine health medtech company focusing on minimally invasive intrauterine treatments, as well as on the Board of Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy.

Register here!

---